M. David

Porphyrin analogues as novel antagonists of fibroblast growth factor and vascular endothelial growth factor receptor binding that inhibit endothelial cell proliferation, tumor progression, and metastasis.

N. Galili, A. Yayon, A. Segev, 2000, Cancer research.

Heparin‐like inhibitory activity to fibroblast growth factor‐2 in wound fluids of patients with chronic skin ulcers and its modulation during wound healing

A. Yayon, D. Aviezer, M. David, 2001, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

Effect of Heparin on Tissue Binding Activity of Fibroblast Growth Factor and Heparin-Binding Epidermal Growth Factor in Experimental Colitis in Rats

A. Yayon, M. David, A. Levine, 2002, Pediatric Research.

Basic fibroblast growth factor: a potential inhibitor of glutamine synthetase expression in injured neural tissue

A. Yayon, M. David, A. Herschkovitz, 2001, Journal of neurochemistry.

Electrical impedance scanning: a new approach to skin cancer diagnosis

Orna Filo, Avner Yayon, Yael A. Glickman, 2003, Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging.